Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05NOG
|
||||
Former ID |
DIB008667
|
||||
Drug Name |
Targeted ranpirnase conjugates
|
||||
Synonyms |
AC RN-321; RN-321; RRNP-EGF; Targeted ranpirnase conjugates (cancer); Polyanhydride-bound Onconase, Alfacell; Polyanhydride-bound ranpirnase, Alfacell; Targeted Onconase conjugates (cancer), Alfacell; Targeted ranpirnase conjugates (cancer), Alfacell; Onconase-mAb conjugate, Alfacell/NCI; Ranpirnase-mAb conjugate, Alfacell/NCI
|
||||
Drug Type |
Antibody
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Preclinical | [548045] | ||
Company |
Tamir Biotechnology Inc
|
||||
Target and Pathway | |||||
Target(s) | B-cell receptor CD22 | Target Info | [550223] | ||
PANTHER Pathway | B cell activation | ||||
Pathway Interaction Database | BCR signaling pathway | ||||
WikiPathways | B Cell Receptor Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.